-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million.
  • SCWorx (NASDAQ:WORX) stock increased by 13.28% to $1.62.
  • Stereotaxis (AMEX:STXS) stock moved upwards by 11.86% to $0.94. The company's market cap stands at $84.4 million.
  • Radiopharm Theranostics (NASDAQ:RADX) shares increased by 8.89% to $0.97. The company's market cap stands at $13.9 million.
  • Imunon (NASDAQ:IMNN) stock increased by 8.88% to $0.98. The company's market cap stands at $23.0 million.
  • Kala Bio (NASDAQ:KALA) shares moved upwards by 8.72% to $0.19. The company's market cap stands at $3.3 million.

Losers

  • Nurix Therapeutics (NASDAQ:NRIX) shares fell 31.9% to $17.59 during Wednesday's pre-market session. The company's market cap stands at $2.8 billion.
  • Baird Medical Investment (NASDAQ:BDMD) stock declined by 12.83% to $0.1. The market value of their outstanding shares is at $3.7 million.
  • Nuwellis (NASDAQ:NUWE) shares declined by 11.38% to $5.24. The company's market cap stands at $2.3 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) shares declined by 10.74% to $1.58. The company's market cap stands at $5.8 million.
  • Protalix BioTherapeutics (AMEX:PLX) stock decreased by 10.73% to $2.33. The market value of their outstanding shares is at $210.2 million.
  • RxSight (NASDAQ:RXST) shares fell 9.59% to $4.15. The company's market cap stands at $190.9 million. The company's, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending